Chinook alums reunite following exit to Novartis; The first board appointment for Recursion’s Chris Gibson
→ Tom Frohlich has signed on as CEO of autoimmune disease specialist Jade Biosciences, a company in the Paragon portfolio that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
